SCHEMBL9749804

SCHEMBL9749804

COC(=O)CCc1nsnc1OCC(O)CNC(C)(C)C

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 6/20 0.50
ADRB1 P08588 6/20 0.50
ADRB3 P13945 5/20 0.50
CYP2D6 P10635 2/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
HTR1A P08908 1/20 0.50
NFKB1 P19838 1/20 0.50
DRD1 P21728 1/20 0.50
SIGMAR1 Q99720 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.48
BLM P54132 1/20 0.48
MEN1 O00255 1/20 0.40
KMT2A Q03164 1/20 0.40
GLA P06280 1/20 0.38
MAPT P10636 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9749811 0.90 ADRB2 (0.47) ADRB2ADRB1ADRB3CYP2D6CYP1A2
SCHEMBL9749852 0.90 ADRB2 (0.41) ADRB2ADRB1ADRB3CYP2D6CYP1A2
SCHEMBL9749902 0.89 SMN1; SMN2 (0.52) ADRB2ADRB1ADRB3CYP2D6CYP1A2
SCHEMBL10984749 0.85 ADRB2 (0.43) ADRB2ADRB1ADRB3CYP2D6CYP1A2
SCHEMBL9749867 0.85 ADRB2 (0.56) ADRB2ADRB1ADRB3CYP2D6CYP1A2
SCHEMBL9749863 0.82 ADRB2 (0.33) ADRB2ADRB1ADRB3CYP2D6CYP1A2
SCHEMBL11753852 0.81 CYP2D6 (0.57) ADRB2ADRB1ADRB3CYP2D6CYP1A2
SCHEMBL11753865 0.81 CYP2D6 (0.57) ADRB2ADRB1ADRB3CYP2D6CYP1A2
SCHEMBL10997074 0.81 CASR (0.41) ADRB2ADRB1ADRB3CYP2D6CYP1A2
SCHEMBL10994091 0.80 ADRB2 (0.43) ADRB2ADRB1ADRB3CYP2D6CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0131006-B1 ESTERS OF 3-(3-SUBSTITUTED-AMINO-2-HYDROXYPROPOXY)-4-SUBSTITUTED-1,2,5-THIADIAZOLE DERIVATIVES THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1992-06-10 EP disclosed
EP-0131006-A4 ESTERS OF 3-(3-SUBSTITUTED-AMINO-2-HYDROXYPROPOXY)-4-SUBSTITUTED-1,2,5-THIADIAZOLE DERIVATIVES. AMERICAN HOSPITAL SUPPLY CORP (US) 1985-06-06 EP disclosed
US-4508725-A BETA-ADRENERGIC BLOCKING AGENTS; GLAUCOMA TREATMENT AMERICAN HOSPITAL SUPPLY CORPORATION (US) 1985-04-02 US disclosed
EP-0131006-A1 ESTERS OF 3-(3-SUBSTITUTED-AMINO-2-HYDROXYPROPOXY)-4-SUBSTITUTED-1,2,5-THIADIAZOLE DERIVATIVES. AMERICAN HOSPITAL SUPPLY CORP (US) 1985-01-16 EP disclosed
WO-1984002525-A1 ESTERS OF 3-(3-SUBSTITUTED-AMINO-2-HYDROXYPROPOXY)-4-SUBSTITUTED-1,2,5-THIADIAZOLE DERIVATIVES AMERICAN HOSPITAL SUPPLY CORP (US) 1984-07-05 WO disclosed